MedTrace Logo

Premixed, Sequential and Manually Mixed Administration of Intrathecal Fentanyl and Bupivacaine in Cesarean Section

NCT06820203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-07-25

No results posted yet for this study

Summary

This study aims to distinguish between premixed, sequential, and manually mixed administration of intrathecal fentanyl and bupivacaine in cesarean section.

Conditions

  • Premixed
  • Sequential
  • Manually Mixed
  • Intrathecal
  • Fentanyl
  • Bupivacaine
  • Cesarean Section

Interventions

DRUG

Fentanyl and Bupivacaine

Patients will receive premixed intrathecal fentanyl and bupivacaine in the same syringe.

DRUG

Fentanyl and Bupivacaine

Patients will receive intrathecal fentanyl and bupivacaine in separate syringes.

DRUG

Fentanyl and Bupivacaine

Patients will receive manually mixed intrathecal fentanyl and bupivacaine in the same syringe.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-12
Primary Completion
2025-07-15
Completion
2025-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06820203 on ClinicalTrials.gov